191 related articles for article (PubMed ID: 26882233)
1. The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.
Beck RW
J Neuroophthalmol; 2016 Mar; 36(1):1-3. PubMed ID: 26882233
[No Abstract] [Full Text] [Related]
2. Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.
Espino Barros Palau A; Morgan ML; Yalamanchili S; Lee AG
Can J Ophthalmol; 2016 Aug; 51(4):e121-e125. PubMed ID: 27521679
[No Abstract] [Full Text] [Related]
3. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
ten Hove MW; Friedman DI; Patel AD; Irrcher I; Wall M; McDermott MP;
J Neuroophthalmol; 2016 Mar; 36(1):13-9. PubMed ID: 26587993
[TBL] [Abstract][Full Text] [Related]
4. Metamorphopsia as an initial complaint of idiopathic intracranial hypertension.
Warner JE; Katz BJ
Arch Ophthalmol; 2005 Jul; 123(7):1003-6. PubMed ID: 16009846
[No Abstract] [Full Text] [Related]
5. Idiopathic intracranial hypertension.
Sinclair AJ; Woolley R; Mollan SP
JAMA; 2014 Sep; 312(10):1059-60. PubMed ID: 25203090
[No Abstract] [Full Text] [Related]
6. Idiopathic intracranial hypertension--reply.
Wall M; McDermott M; Kupersmith M
JAMA; 2014 Sep; 312(10):1060. PubMed ID: 25203092
[No Abstract] [Full Text] [Related]
7. Idiopathic intracranial hypertension and sickle cell disease: two case reports.
Segal L; Discepola M
Can J Ophthalmol; 2005 Dec; 40(6):764-7. PubMed ID: 16391644
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial.
Horton JC
JAMA; 2014 Apr 23-30; 311(16):1618-9. PubMed ID: 24756510
[No Abstract] [Full Text] [Related]
9. Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension.
Micieli JA; Al-Obthani M; Sundaram AN
Can J Ophthalmol; 2014 Aug; 49(4):e99-e102. PubMed ID: 25103671
[No Abstract] [Full Text] [Related]
10. Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?
Kaufman DI; Friedman DI
J Neuroophthalmol; 2017 Jun; 37(2):182-186. PubMed ID: 28376023
[No Abstract] [Full Text] [Related]
11. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
[TBL] [Abstract][Full Text] [Related]
12. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
Celebisoy N; Gökçay F; Sirin H; Akyürekli O
Acta Neurol Scand; 2007 Nov; 116(5):322-7. PubMed ID: 17922725
[TBL] [Abstract][Full Text] [Related]
14. A Young Woman With Headaches and Blurry Vision.
Scott NL; Stryjewski TP; Rizzo JF
JAMA Ophthalmol; 2017 Jun; 135(6):663-664. PubMed ID: 28301650
[No Abstract] [Full Text] [Related]
15. Respiratory Complications Associated With Acetazolamide Use in the Management of Idiopathic Intracranial Hypertension.
Costello F; Skolnik K; Sarna J; Varughese R
J Neuroophthalmol; 2019 Dec; 39(4):511-512. PubMed ID: 31609839
[No Abstract] [Full Text] [Related]
16. Acetazolamide for the treatment of idiopathic intracranial hypertension.
Supuran CT
Expert Rev Neurother; 2015; 15(8):851-6. PubMed ID: 26154918
[TBL] [Abstract][Full Text] [Related]
17. Update on Idiopathic Intracranial Hypertension.
Wall M
Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
[TBL] [Abstract][Full Text] [Related]
18. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
Cello KE; Keltner JL; Johnson CA; Wall M;
J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
[TBL] [Abstract][Full Text] [Related]
19. An 18-year-old woman with unexplained vision loss.
Leonen KE
J Emerg Nurs; 2002 Apr; 28(2):179-80. PubMed ID: 11960137
[No Abstract] [Full Text] [Related]
20. Intracranial idiopathic hypertension: 1-year follow-up study.
D'Amico D; Curone M; Erbetta A; Farago' G; Bianchi-Marzoli S; Ciasca P; Bussone G; Chiapparini L
Neurol Sci; 2014 May; 35 Suppl 1():177-9. PubMed ID: 24867861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
